Portfolio company
Aignostics
Germany · £38.8m raised
Raised
£38.8m
Latest stage
Series B
Rounds recorded
2
Backed by
2 investors
Sectors
About
Aignostics develops AI-powered digital pathology software and foundation models for biopharmaceutical companies, academic researchers and clinical laboratories to improve disease diagnosis and drug development.
SourceFunding history · 2
Similar companies
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
Mindpeak
This company develops artificial intelligence software for automated tissue analysis and cancer diagnostics for pathology laboratories and pharmaceutical firms.
TileBio
TileBio develops artificial intelligence foundation models for digital pathology to assist clinicians and pharmaceutical companies with cancer diagnosis, biomarker discovery and drug development.
Proscia
This company develops a digital pathology platform and artificial intelligence software for laboratories, hospitals and biopharmaceutical organisations.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
Ibex Medical
This company develops artificial intelligence software for cancer diagnostics to assist pathologists in labs and hospitals with biopsy analysis and quality control.
Ibex
Ibex develops artificial intelligence software for cancer diagnostics to assist pathologists and laboratories with biopsy analysis and workflow efficiency.
Imagenomix
The company develops an artificial intelligence platform that predicts cancer mutations from pathology images for healthcare providers and biopharma companies.
